ACC-2026
ACC-2026-mobile

Transthyretin Amyloidosis (ATTR)

American College of Cardiology (ACC) 2026

Congress Details

calander28-30 March, 2026 | USA

locationNew Orleans, LA, USA

The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to vutrisiran▼. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].

Oral

Congress Materials

ACC-2026-1a
icon Presentation Type
Poster
location icon Location
New Orleans, LA, USA
icon Title
Post Hoc Analysis of Diastolic Dysfunction in the HELIOS-B Study of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
mic Presenter

Jose Gonzalez-Costello

Bellvitge University Hospital, Barcelona, Spain

ACC-2026-2a
icon Presentation Type
Poster
location icon Location
New Orleans, LA, USA
icon Title
Polypharmacy and Potential for Drug–Drug Interactions Among Patients With ATTR-CM Initiating Tafamidis
mic Presenter

Robert DiDomenico

Retzky College of Pharmacy, IL, USA

ACC-2026-3a
icon Presentation Type
Poster
location icon Location
New Orleans, LA, USA
icon Title
Impact of Vutrisiran on the Components of Quality of Life in Transthyretin Cardiomyopathy (ATTR-CM)
mic Presenter

Yasuhiro Hamatani

Brigham and Women's Hospital, MA, USA

ACC-2026-4a
icon Presentation Type
Poster
location icon Location
New Orleans, LA, USA
icon Title
Real-World Adherence and Persistence With Vutrisiran, an RNA Interference Therapeutic for the Treatment of Transthyretin Amyloidosis
mic Presenter

Teresa Kauf, PhD

Alnylam Pharmaceuticals, MA, US

ACC-2026-5a
icon Presentation Type
Poster
location icon Location
New Orleans, LA, USA
icon Title
Vutrisiran Reduces the Risk of Developing Advanced Disease and Demonstrates Benefit in Patients Who Do Develop Advanced Disease in ATTR-CM: Analysis From the HELIOS-B Study
mic Presenter

Ronald Witteles

Stanford University, CA, USA

Associated Materials

Transthyretin Amyloidosis (ATTR)

The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement

Orphanet Journal of Rare Diseases

Author(s)

Chafic Karam, Colleen Moffit, Catherine Summers, et al

November 2024

Preparation Date
March 2026
Job Code
MB-UK-00179
Preparation Date
June 2026
Job Code
MB-UK-00206